{"name":"Arrien Pharmaceuticals","slug":"arrien-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQMkFqR3R5Mmw4WWdUTWVvN0xYM3R4YjVta1RrN0hZSnlNci02aHUtM2FVWEY3TXB2bDk2bEU5Sy1FOVZBZ0JScmtLdjZMc2lfMU9WNVIxblVBSkt2ZGFrNjVsdVNoU0RoS1o0MU9wNnh3RU84ZFJYWVFld1NmY3l2UmtRNnhJdFVpbnNneGhlQWwyNnpKa1Fyak1wVmNiTVgzUjNPdFhLZ0xIZF9FclItdmt0cG02UlVGM1pSdWEtZ2NZTUZWMEYySlJSbk82R090X0ZaZWw0dzluYVhkS3kzTXJTZTBySmJHNXFIcWF4QUNrQXY0UW9ROVhwaVVjTDFUUEhFMHAtaldMemhHTC1kOUVKRmZnRWFKaXZoRm1hOA?oc=5","date":"2025-08-14","type":"trial","source":"globenewswire.com","summary":"Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma - globenewswire.com","headline":"Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxQT0pkMkxEYXAzQmNNOEFLNkN1S1RaazBYUGdNS29VVjNDeXotZEpuUGRKSURyQi1LY1dhWGJvcnJ1d2s0VEw4ZUhSSDNCZTBmZzJxcWJrUkdycUpuV0lmOEFNakFpT2otaEcyLWZlX0F6cVV1Q0dxczZXY0VJbUYzVTFlR2dHYkExTXFzdnYxZ3ZlZWpBV2xSamFXcklJejNFQmhvQ2RTT2ZwLU9meXoxa1dGQ2ZwTzZZRHRzR1d4OFE4WXctVzFPWHBQZi1MYXl6NENOTGxmWG53eWdDYVUwM2lhQVBIM04zRnhfUVE1dVE0dG5WUnNzaTF4X2hyUXhwekFkT1hjakRJUTFLNVNGcmRrN2xwMnNfX0dTdnEwSXowRFExOGY1NkNOalJieDFtRVhnTzFlMHQwUUZ3S1pSWXNSNERvZUtx?oc=5","date":"2025-03-03","type":"trial","source":"globenewswire.com","summary":"JAK Inhibitors Clinical Trial Pipeline Appears Robust With - globenewswire.com","headline":"JAK Inhibitors Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}